HCV Infection and Miravirsen

被引：58
|
作者：
Sanchez-Nino, Maria D. [1 ]
Ortiz, Alberto [2 ]
机构：
[1] Hosp La Paz, Inst Hlth Res, Madrid, Spain
[2] Fdn Jimenez Diaz, Inst Invest Sanitaria, E-28040 Madrid, Spain
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2013年 / 369卷 / 09期
关键词：
D O I：
10.1056/NEJMc1307787
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：877 / 878
页数：2
相关论文
共 50 条
  • [1] HCV Infection and Miravirsen REPLY
    Janssen, Harry L. A.
    Kauppinen, Sakari
    Hodges, Michael R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (09) : 878 - 878
  • [2] SEQUENCE ANALYSIS OF HCV VARIANTS FROM A PHASE IIA TRIAL OF MIRAVIRSEN (MIR), AN OLIGONUCLEOTIDE TARGETING MIR-122, IN TREATMENT NAIVE PATIENTS WITH CHRONIC HCV INFECTION
    Patick, A. K.
    Chen, A.
    van Doorn, L. J.
    van der Veer, E.
    Zeh, K.
    Raney, A. K.
    Hodges, M. R.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S476 - S476
  • [3] PLASMA PHARMACOKINETICS OF MIRAVIRSEN IN HUMANS
    Persson, R.
    Bagger, Y.
    Borgesen, H.
    Hodges, M. R.
    King, B. D.
    Levin, A. A.
    NUCLEIC ACID THERAPEUTICS, 2011, 21 (05) : A23 - A23
  • [4] Miravirsen does not interact with telaprevir
    Persson, R.
    Karim, A.
    Rodriguez-Orengo, J.
    Levin, A.
    King, B.
    Chen, A.
    Zeh, K.
    Hodges, M.
    JOURNAL OF VIRAL HEPATITIS, 2013, 20 : 22 - 22
  • [5] MIRAVIRSEN SODIUM MiR-122 Inhibitor Treatment of Hepatitis C Virus Infection
    Obad, S.
    Orum, H.
    DRUGS OF THE FUTURE, 2013, 38 (06) : 367 - 373
  • [6] Hcv genotypes and pediatric HCV infection
    Bortolotti, F
    Resti, M
    Verucchi, G
    Nebbia, G
    Giacchino, R
    Marazzi, MG
    Marcellini, M
    Barbera, C
    Maggiore, G
    Bartolacci, S
    Guido, M
    JOURNAL OF HEPATOLOGY, 2004, 40 : 137 - 137
  • [7] Intrahepatic HCV levels in chronic HCV infection
    Bonacini, M
    Redeker, AG
    GUT, 1999, 45 (04) : 630 - 630
  • [8] PERSISTENCE OF HCV VIREMIA IN CHRONIC HCV INFECTION
    LOK, ASF
    CHEUNG, R
    CHAN, R
    HEPATOLOGY, 1992, 16 (02) : 563 - 563
  • [9] HCV neutralizing antibodies eradicate HCV infection
    Nature Reviews Gastroenterology & Hepatology, 2014, 11 (11) : 642 - 642
  • [10] CCRΔ32 in HCV infection, HCV/HIV co-infection, and HCV-related diseases
    Ellwanger, Joel Henrique
    Leal, Bruna Kulmann
    Valverde-Villegas, Jacqueline Maria
    Simon, Daniel
    Marangon, Camila Guerra
    Mattevi, Vanessa Sune
    Lazzaretti, Rosmeri Kuhmmer
    Sprinz, Eduardo
    Kuhmmer, Regina
    Bogo Chies, Jose Artur
    INFECTION GENETICS AND EVOLUTION, 2018, 59 : 163 - 166
12345